CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

Ever wondered what's in your dog's DNA? We put the four most popular dog DNA kits to the test to see which gave the best ...

Crispant analysis in zebrafish serves as a powerful tool for the rapid functional screening of genes implicated in bone fragility disorders, like osteogenesis imperfecta and osteoporosis.

The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

New research adds to our understanding of the function of the human genome. An international team of researchers has made ...

CBI is taking 500-plus days on average to process kits used to preserve evidence of sexual assault — almost six times as long ...

So while scientists keep venturing into tweaking our DNA, it is worth taking the time to fully understand what CRISPR is, and what the actual benefits and possibilities are. CRISPR is short for ...

“I don’t wish this experience on anyone. The backlog of DNA cases and rape kits is unacceptable and the state needs to take clearing the backlog seriously.” On Monday, lawyers for Willford ...

CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing ...